These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2288829)

  • 1. An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.
    Tingle MD; Coleman MD; Park BK
    Br J Clin Pharmacol; 1990 Dec; 30(6):829-38. PubMed ID: 2288829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.
    Tingle MD; Coleman MD; Park BK
    Br J Clin Pharmacol; 1991 Jul; 32(1):120-3. PubMed ID: 1888631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues.
    Riley RJ; Roberts P; Coleman MD; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1990 Sep; 30(3):417-26. PubMed ID: 2223420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias.
    Tingle MD; Park BK
    Br J Clin Pharmacol; 1993 Jul; 36(1):31-8. PubMed ID: 8373710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro--II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma.
    Coleman MD; Jacobus DP
    Biochem Pharmacol; 1993 Oct; 46(8):1363-8. PubMed ID: 8240384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the toxicity of analogues of dapsone in-vitro using rat, human and heterologously expressed metabolizing systems.
    Coleman MD; Smith SN; Kelly DE; Kelly SL; Seydel JK
    J Pharm Pharmacol; 1996 Sep; 48(9):945-50. PubMed ID: 8910859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro.
    Coleman MD; Jacobus DP
    Biochem Pharmacol; 1993 Mar; 45(5):1027-33. PubMed ID: 8461032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the haemotoxicity of dapsone: the importance of the sulphonyl group.
    Mahmud R; Tingle MD; Maggs JL; Cronin MT; Dearden JC; Park BK
    Toxicology; 1997 Feb; 117(1):1-11. PubMed ID: 9020194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadal influence on the metabolism and haematological toxicity of dapsone in the rat.
    Coleman MD; Tingle MD; Winn MJ; Park BK
    J Pharm Pharmacol; 1990 Oct; 42(10):698-703. PubMed ID: 1982141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes.
    Pirmohamed M; Coleman MD; Hussain F; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1991 Sep; 32(3):303-10. PubMed ID: 1685664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. IV: Implications for the development of agranulocytosis.
    Coleman MD; Simpson J; Jacobus DP
    Biochem Pharmacol; 1994 Oct; 48(7):1349-54. PubMed ID: 7945432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation into the haematological toxicity of structural analogues of dapsone in-vivo and in-vitro.
    Coleman MD; Tingle MD; Hussain F; Storr RC; Park BK
    J Pharm Pharmacol; 1991 Nov; 43(11):779-84. PubMed ID: 1686906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dapsone-induced blood dyscrasia in the mouse: evidence for the role of an active metabolite.
    Ahmadi M; Khalaf LF; Smith HJ; Nicholls PJ
    J Pharm Pharmacol; 1996 Feb; 48(2):228-32. PubMed ID: 8935178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450-dependent toxicity of dapsone in human erythrocytes.
    Ganesan S; Sahu R; Walker LA; Tekwani BL
    J Appl Toxicol; 2010 Apr; 30(3):271-5. PubMed ID: 19998329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the presence of trimethoprim in the rat.
    Coleman MD; Russell RM; Tingle MD; Park BK
    J Pharm Pharmacol; 1992 Feb; 44(2):114-8. PubMed ID: 1352810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.
    Reilly TP; Woster PM; Svensson CK
    J Pharmacol Exp Ther; 1999 Mar; 288(3):951-9. PubMed ID: 10027831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
    Coleman MD; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1989 Oct; 28(4):389-95. PubMed ID: 2590600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
    Coleman MD; Scott AK; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1990 Nov; 30(5):761-7. PubMed ID: 2271376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of taxol by human and rat liver in vitro: a screen for drug interactions and interspecies differences.
    Jamis-Dow CA; Klecker RW; Katki AG; Collins JM
    Cancer Chemother Pharmacol; 1995; 36(2):107-14. PubMed ID: 7767945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. III: Effect of diabetes.
    Coleman MD; Simpson J; Jacobus DP
    Biochem Pharmacol; 1994 Oct; 48(7):1341-7. PubMed ID: 7945431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.